Cargando…

Low Dose of Paclitaxel Combined with XAV939 Attenuates Metastasis, Angiogenesis and Growth in Breast Cancer by Suppressing Wnt Signaling

Triple-negative breast cancer (TNBC) accounts for 15% of overall breast cancer. A lack of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2 receptor) makes TNBC more aggressive and metastatic. Wnt signaling is one of the important pathways in the...

Descripción completa

Detalles Bibliográficos
Autores principales:	Shetti, Dattatrya, Zhang, Bao, Fan, Conghui, Mo, Canlong, Lee, Bae Hoon, Wei, Kun
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6721645/ https://www.ncbi.nlm.nih.gov/pubmed/31416135 http://dx.doi.org/10.3390/cells8080892

Ejemplares similares

Bioactivity Studies of Hesperidin and XAV939
por: Fazary, Ahmed E., et al.
Publicado: (2021)

Erianin Inhibits Proliferation and Induces Apoptosis of HaCaT Cells via ROS-Mediated JNK/c-Jun and AKT/mTOR Signaling Pathways
por: Mo, Canlong, et al.
Publicado: (2019)

XAV939 inhibits the proliferation and migration of lung adenocarcinoma A549 cells through the WNT pathway
por: Li, Chong, et al.
Publicado: (2018)

Wnt inhibitor XAV939 suppresses the viability of small cell lung cancer NCI-H446 cells and induces apoptosis
por: Guo, Wenxuan, et al.
Publicado: (2017)

XAV939-Mediated ARTD Activity Inhibition in Human MB Cell Lines
por: Renna, Cristiano, et al.
Publicado: (2015)

Treatment with XAV-939 prevents in vitro calcification of human valvular interstitial cells
por: Dittfeld, Claudia, et al.
Publicado: (2018)

Targeting Wnt/β-catenin signaling using XAV939 nanoparticles in tumor microenvironment-conditioned macrophages promote immunogenicity
por: Pundkar, Chetan, et al.
Publicado: (2023)

Tankyrase 1 inhibitior XAV939 increases chemosensitivity in colon cancer cell lines via inhibition of the Wnt signaling pathway
por: WU, XUEFANG, et al.
Publicado: (2016)

Ocular Wnt/β-Catenin Pathway Inhibitor XAV939-Loaded Liposomes for Treating Alkali-Burned Corneal Wound and Neovascularization
por: Zhong, Yueyang, et al.
Publicado: (2021)

Docetaxel Resistance in Castration-Resistant Prostate Cancer: Transcriptomic Determinants and the Effect of Inhibiting Wnt/β-Catenin Signaling by XAV939
por: Pudova, Elena, et al.
Publicado: (2022)

Tankyrase inhibitor XAV-939 enhances osteoblastogenesis and mineralization of human skeletal (mesenchymal) stem cells
por: Almasoud, Nuha, et al.
Publicado: (2020)

XAV939, a tankyrase 1 inhibitior, promotes cell apoptosis in neuroblastoma cell lines by inhibiting Wnt/β-catenin signaling pathway
por: Tian, Xiao-Hong, et al.
Publicado: (2013)

miR-29b-3p promotes progression of MDA-MB-231 triple-negative breast cancer cells through downregulating TRAF3
por: Zhang, Bao, et al.
Publicado: (2019)

Author Correction: Tankyrase inhibitor XAV-939 enhances osteoblastogenesis and mineralization of human skeletal (mesenchymal) stem cells
por: Almasoud, Nuha, et al.
Publicado: (2021)

Anticancer effect of XAV939 is observed by inhibiting lactose dehydrogenase A in a 3-dimensional culture of colorectal cancer cells
por: Kim, Dahee, et al.
Publicado: (2019)

The WNT/β-catenin signaling inhibitor XAV939 enhances the elimination of LNCaP and PC-3 prostate cancer cells by prostate cancer patient lymphocytes in vitro
por: Stakheev, Dmitry, et al.
Publicado: (2019)

In Vitro Differentiation of Neural-Like Cells from Human Embryonic Stem Cells by A Combination of Dorsomorphin, XAV939, and A8301
por: Valizadeh-Arshad, Zahra, et al.
Publicado: (2018)

Quantitative Proteomic Analysis of 2D and 3D Cultured Colorectal Cancer Cells: Profiling of Tankyrase Inhibitor XAV939-Induced Proteome
por: Kim, Young Eun, et al.
Publicado: (2018)

Piceatannol attenuates RANKL-induced osteoclast differentiation and bone resorption by suppressing MAPK, NF-κB and AKT signalling pathways and promotes Caspase3-mediated apoptosis of mature osteoclasts
por: Yan, Liuliu, et al.
Publicado: (2019)

Modelling of a targeted nanotherapeutic ‘stroma’ to deliver the cytokine LIF, or XAV939, a potent inhibitor of Wnt–β-catenin signalling, for use in human fetal dopaminergic grafts in Parkinson’s disease
por: Zhao, Jing-Wei, et al.
Publicado: (2014)

RNA sequencing uncovers the key long non-coding RNAs and potential molecular mechanism contributing to XAV939-mediated inhibition of non-small cell lung cancer
por: Yu, Haixiang, et al.
Publicado: (2019)

Circ_MDM2_000139, Circ_ATF2_001418, Circ_CDC25C_002079, and Circ_BIRC6_001271 Are Involved in the Functions of XAV939 in Non-Small Cell Lung Cancer
por: Yu, Haixiang, et al.
Publicado: (2019)

XAV-19 de Xenothera, candidat traitement anti-Covid-19
por: Dalmat, Yann-Mickael
Publicado: (2020)

SUN-939 Case Report: Malignant Pheochromocytoma
por: Lima, Jose Viana, et al.
Publicado: (2020)

Correction to Lancet Neurol 2018; 17: 939–53
Publicado: (2021)

MicroRNA-939 Directly Targets HDGF to Inhibit the Aggressiveness of Prostate Cancer via Deactivation of the WNT/β-Catenin Pathway
por: Situ, Jie, et al.
Publicado: (2020)

Paclitaxel-induced hypothermia and hypoperfusion increase breast cancer metastasis and angiogenesis in mice
por: Ami, Nozomi, et al.
Publicado: (2018)

MicroRNA-939 Directly Targets HDGF to Inhibit the Aggressiveness of Prostate Cancer via Deactivation of the WNT/β-Catenin Pathway [Retraction]
Publicado: (2021)

lncRNA LINC00460 promoted colorectal cancer cells metastasis via miR-939-5p sponging
por: Zhang, Yueyan, et al.
Publicado: (2019)

Development of erianin-loaded dendritic mesoporous silica nanospheres with pro-apoptotic effects and enhanced topical delivery
por: Mo, Canlong, et al.
Publicado: (2020)

Coronary Serum Exosomes Derived from Patients with Myocardial Ischemia Regulate Angiogenesis through the miR-939-mediated Nitric Oxide Signaling Pathway
por: Li, Hao, et al.
Publicado: (2018)

XAV-19, un anti-variant de Sars-CoV-2, BQ.1.1 compris
por: Manus, Jean-Marie
Publicado: (2023)

Regulation of proinflammatory genes by the circulating microRNA hsa-miR-939
por: McDonald, Marguerite K., et al.
Publicado: (2016)

Inflammation potentiates miR-939 expression and packaging into small extracellular vesicles
por: Ramanathan, Sujay, et al.
Publicado: (2019)

P939: THE RELATIONSHIP OF BONE MARROW FIBROSIS WITH EXTRAMEDULLARY DISEASE IN MULTIPLE MYELOMA
por: Konyaoglu, Hilal, et al.
Publicado: (2023)

Applications of Liquid Biopsies in Non-Small-Cell Lung Cancer
por: Pesta, Martin, et al.
Publicado: (2022)

A Retrospective Analysis of the Clinical Impact of 939 Chest Radiographs Using the Medical Records
por: Geijer, Mats, et al.
Publicado: (2012)

Serum adiponectin concentration in 2,939 Japanese men undergoing screening for prostate cancer
por: Ikeda, Atsushi, et al.
Publicado: (2015)

The PALB2 p.Leu939Trp mutation is not associated with breast cancer risk
por: Catucci, Irene, et al.
Publicado: (2016)

Epidemiology of lung cancer in northeast of Iran: A 25-year study of 939 patients
por: Salehi, Mahta, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_rhalvaki1skuffoab2h1rvgi91